Vericel Corporation
- VCEL
- NASDAQ
- Biotechnology
- Biotech
- Healthcare
$40.13
Today −2.17%Quote Oct 16, 2026, 08:00 PM UTC
+0.25%over the last month
Max drawdown −3.6%From 1-month high −2.3%3 months −12.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.05B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$60.67
+51.2% from here
Floor
$39.13
2.5% below price
Where the price sits
14 analysts
Analyst range, low to high
$52.00$70.00
- Price $40.13
- Resistance $40.35
- Consensus $60.67
The price is right under resistance. Analysts' average target sits about 51% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VCELPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
398